Josh Feldman, Associate Director of Patient Insights at Inspire, will address these challenges during an upcoming Xtalks webinar on July 23, 2026. Drawing from the Ipsos Pulse of 2026 study, the session examines why 40% of therapeutic discussions fail to result in action. Feldman plans to dissect the psychological friction points and payer hurdles that prevent patients from adhering to recommended treatments, even when clinical markers might suggest otherwise.
In section Releases
Closing the Gap Between Clinical Data and Patient Reality
Patients rarely manage a single diagnosis in isolation, yet traditional data models often ignore the complex web of multi-morbidity. With regulators and payers increasingly demanding evidence that mirrors actual lived experiences, the industry faces a critical barrier in evaluating treatment value through clean but incomplete data sets.
The discussion centers on elevating research-grade data by integrating patient-reported outcomes with traditional clinical metrics. By capturing functional impacts—such as chronic fatigue or daily living struggles—life sciences teams can better understand the hidden drivers of treatment failure. Furthermore, the presentation will emphasize the necessity of identity verification to ensure patient cohorts remain free of bot interference, a growing requirement for data that must withstand rigorous regulatory scrutiny.
Comments (0)
No comments yet. Be the first!